Similarly, studies using the pharmacological mitochondria-targeted antioxidants MitoQ or MitoTEMPO have shown improvements in fasting blood glucose, insulin, lipid levels, and glucose and insulin tolerance in rodent models of high-fat diet (7–8 weeks)-induced obesity [36,37,38]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.